• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    ZeroStack Announces $107 Million Cryptocurrency Financing, Elimination of Convertible Note and Plan to Redomicile to Texas

    3/31/26 5:01:00 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ZSTK alert in real time by email

    Toronto, Ontario--(Newsfile Corp. - March 31, 2026) - Zerostack Corp. (NASDAQ:ZSTK) ("ZeroStack" or the "Company"), an artificial intelligence ("AI") focused asset management company, today announced that it has entered into definitive agreements for a private $107 million cryptocurrency financing transaction (the "Financing") that will significantly expand its digital asset holdings, strengthen its balance sheet, and position the Company for long-term growth in decentralized AI.

    Investors in the Financing contributed an aggregate of 142,232,948 native tokens of the Zero Gravity (0G) blockchain (the "0G Tokens") to Texas Blocker Corp., a Texas corporation formed by ZeroStack to facilitate the Financing ("Texas Blocker"), in exchange for an aggregate of 9,104,614 shares of common stock of Texas Blocker (the "Texas Blocker Shares"), which will be exchanged on a one-for-one basis for ZeroStack Shares (as defined below). The aggregate fair market value of the contributed 0G Tokens was deemed to be $107 million in accordance with a mutually agreed valuation. The Financing was done at a deemed price of $11.7931 per ZeroStack Share.

    Concurrently, the investors, Texas Blocker and ZeroStack entered into a share exchange agreement pursuant to which ZeroStack will issue an aggregate of 9,104,614 common shares (including pre-funded warrants) of the Company (the "ZeroStack Shares") in exchange for all of the issued and outstanding Texas Blocker Shares, upon receipt of shareholder approval of both ZeroStack and Texas Blocker (the "Exchange"). Prior to the Exchange, under the terms of a unanimous stockholders' agreement, holders of Texas Blocker Shares are not permitted to transfer any Texas Blocker Shares, subject to limited exceptions.

    Upon closing of the Exchange, which is expected to occur on or around July 5, 2026, Texas Blocker will become a wholly-owned subsidiary of ZeroStack and ZeroStack expects to hold approximately 21% of the total supply of the 0G Tokens, establishing one of the largest strategic positions in the 0G Token ecosystem.

    The Exchange is subject to customary closing conditions, including approval of shareholders of ZeroStack to approve the issuance of ZeroStack Shares under applicable Nasdaq Stock Market rules and approval of the stockholders of Texas Blocker by written consent resolution. ZeroStack has agreed to file a re-sale registration statement on Form S-3 registering the ZeroStack Shares to be issued in the Exchange.

    In connection with the Financing, the Company also announced:

    • the extinguishment of the 0G Token-denominated convertible note held by Zero Gravity Labs Inc. pursuant to a note settlement agreement executed concurrently with the definitive agreements for the Financing, resulting in the Company becoming debt-free; and

    • the plan to redomicile from its current jurisdiction of incorporation, the Province of Ontario, to the State of Texas, which remains subject to approval of shareholders of the Company.

    There can be no assurance that the requisite shareholder approvals will be obtained and that the customary closing conditions will be satisfied for either the Exchange or the planned redomicile or that that the Financing will be completed as proposed.

    Strategic Transformation

    The $107 million cryptocurrency financing is expected to materially strengthen the Company's balance sheet while transforming it into a leading public vehicle for AI-native exposure. By securing a significant ownership stake in the 0G Token ecosystem, the Company aims to combine long-term token appreciation potential with recurring staking rewards.

    "This transaction marks a defining milestone in our evolution as a public company," said Daniel Reis-Faria, Chief Executive Officer of ZeroStack. "By investing in approximately 21% of the total 0G token supply, we are establishing a strategic position in what we believe is foundational infrastructure for decentralized AI. We are not merely investing in a token — we are investing in the future architecture of distributed intelligence."

    Mr. Reis-Faria continued, "Simultaneously, we are strengthening our balance sheet by eliminating our convertible debt, positioning the Company to operate debt-free, and planning to redomicile to Texas — a jurisdiction that is supportive of digital assets and innovation. Together, these actions align our capital structure, regulatory framework, and asset strategy around a unified AI-focused vision."

    AI-Focused Asset Management Strategy

    The Company's strategy centers on building a diversified portfolio of AI-enabling digital assets and infrastructure positions designed to generate both capital appreciation and recurring income. The 0G token position is expected to serve as a cornerstone of this strategy, providing exposure to decentralized computing and AI data infrastructure.

    Management believes that the convergence of blockchain and AI represents one of the most significant technological transformations of the coming decade. Through this transaction, the Company aims to offer public market investors direct exposure to that growth via a Nasdaq-listed platform.

    About ZeroStack Corp.

    ZeroStack Corp. is the first Nasdaq-listed asset management company focused on providing exposure to decentralized AI. The Company also operates a global pharmaceutical distribution business through its wholly owned subsidiary, Phatebo GmbH. For more information, visit https://zerostack.ai/.

    Cautionary Statement Concerning Forward-Looking Statements

    This press release may contain "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect the Company's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar words or expressions generally identify forward-looking statements. These forward-looking statements include, but are not limited to, express or implied statements regarding: the Company's business plans, strategy, financial position and expectations; expectations for the 0G Token and AI; the satisfaction of customary closing conditions related to the Exchange and to complete the Financing; the date on which the Exchange is expected to close; the Company's ability to obtain shareholder approval for the Exchange and/or planned redomicile; Texas Blocker's ability to obtain stockholder approval by written consent for the Exchange. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in the Company's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") February 27, 2026, as such factors may be updated from time to time in the Company's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in the Company's filings with the SEC. While forward-looking statements reflect the Company's good faith beliefs, they are not guarantees of future performance. The Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to the Company (or to third parties making the forward-looking statements).

    Investor Contact: ir@zerostack.ai

    Media Contact: zerostack@dittopr.co

    Corporate Logo

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290750

    Get the next $ZSTK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ZSTK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ZSTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Heinrich Michael bought $3,479,013 worth of shares (4,608,575 units at $0.75) (SEC Form 4)

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:31:03 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Reis-Faria Daniel exercised 5,954,743 in-the-money shares at a strike of $0.00 (SEC Form 4)

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:26:15 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CFO Vaiman Dany

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:21:25 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    SEC Filings

    View All

    ZeroStack Corp. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - ZeroStack Corp. (0001790169) (Filer)

    7/20/26 4:02:11 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by ZeroStack Corp.

    EFFECT - ZeroStack Corp. (0001790169) (Filer)

    6/18/26 12:15:34 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by ZeroStack Corp.

    424B3 - ZeroStack Corp. (0001790169) (Filer)

    6/17/26 4:53:30 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Heinrich Michael bought $3,479,013 worth of shares (4,608,575 units at $0.75) (SEC Form 4)

    4 - ZeroStack Corp. (0001790169) (Issuer)

    7/20/26 6:31:03 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ZeroStack Announces Results of 2026 Annual and Special Meeting of Shareholders, Provides Phatebo Purchase Orders Update and Announces Closing of Previously Announced Cryptocurrency Financing

    Dallas, Texas--(Newsfile Corp. - July 20, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) ("ZeroStack" or the "Company"), the first Nasdaq-listed, AI-focused asset management company, held its 2026 Annual and Special Meeting of Shareholders (the "Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Meeting are as follows: Proposal 1: Election of five directors to the board of directors of the Company (the "Board") to hold office until the Company's 2027 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified. If Proposal 7 is approved, the Board will be staggered as described in the proxy statement/pros

    7/20/26 4:01:00 PM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZeroStack Corp. Secures Purchase Orders for up to US$14.7 Million of Inventory from Two Pharmaceutical Companies

    Toronto, Ontario--(Newsfile Corp. - July 9, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) (the "Company" or "ZeroStack"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has secured pharmaceutical distribution purchase orders for up to approximately US$14.7 million (EUR 12.9 million) of inventory in Germany from two companies (the "Orders"). The Orders are expected to be fulfilled through the Company's wholly owned German subsidiary, Phatebo GmbH ("Phatebo").Phatebo has operated as a pharmaceutical distributor in Europe for more than then years and serves as the Company's primary operating subsidiary. In connection with ZeroStack's long-term strategy, Phatebo co

    7/9/26 8:01:00 AM ET
    $ZSTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DeFi Dev Corp. Announces Strategic Leadership Transition of DisclaimerCoin (DONT) to Dedicated Ecosystem Team

    BOCA RATON, FL, July 08, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company"), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced the strategic transition of leadership for DisclaimerCoin ("DONT"), the world’s first publicly traded company-created memecoin, to Daniel Reis-Faria, Chief Executive Officer of Nasdaq-listed ZeroStack Holdings Inc. (NASDAQ:ZSTK), and a dedicated team focused exclusively on growing the DisclaimerCoin ecosystem. The transition represents the next phase in DisclaimerCoin’s evolution. While DFDV pioneered the historic launch of DONT in January 2026, the Company believes th

    7/8/26 9:00:00 AM ET
    $DFDV
    $ZSTK
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ZSTK
    Leadership Updates

    Live Leadership Updates

    View All

    DeFi Dev Corp. Announces Strategic Leadership Transition of DisclaimerCoin (DONT) to Dedicated Ecosystem Team

    BOCA RATON, FL, July 08, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company"), the first U.S. public company with a treasury strategy built to accumulate and compound Solana ("SOL"), today announced the strategic transition of leadership for DisclaimerCoin ("DONT"), the world’s first publicly traded company-created memecoin, to Daniel Reis-Faria, Chief Executive Officer of Nasdaq-listed ZeroStack Holdings Inc. (NASDAQ:ZSTK), and a dedicated team focused exclusively on growing the DisclaimerCoin ecosystem. The transition represents the next phase in DisclaimerCoin’s evolution. While DFDV pioneered the historic launch of DONT in January 2026, the Company believes th

    7/8/26 9:00:00 AM ET
    $DFDV
    $ZSTK
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care